Bionanotechnologies for treatment and diagnosis of Alzheimer's disease
Alzheimer's disease (AD) is the most common cause of dementia and accounts for an estimated 60−80% of cases. This disease usually occurs in the very elderly, where early clinical symptoms are often marked with a decline in memory, reasoning, and planning. Affected individuals are also likely to develop seizures, hypertonicity (increased muscle movements), and incontinence (loss of normal control of the bowel or bladder). Of 5 million cases of dementia in Europe, 3 million are classified as AD, and globally more than 30 million people suffer from AD. In their 2010 report, the Alzheimer's Association (United States) estimated that 5.3 million Americans of all ages have AD, and 96% of this figure corresponds to people aged 65 and older. The same report further states that “one in eight pe...

Fasting Might Boost Chemo's Cancer-Busting Properties
Cancer treatment can be brutal for patients. Many of the tools we have-- chemotherapy , radiation--are big, blunt weapons that deal punishing blows to healthy tissues along with cancerous ones. So the hunt has been on for more and more finely targeted therapies that will attack malignant cells yet minimize damage to patients#39; bodies. [More] (Source: Scientific American Topic - Medical Technology)